The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.
On Tuesday evening, every three issued and outstanding shares of CARA’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the company's...
The brand was a popular choice for fragrances among teenagers in the U.S., according to a Piper Sandler survey.
hares of the company, which is struggling with a declining business and high debt levels, fell over 60% after the report.
CEO Robert Bitterman said the company is optimistic that the clinical trial will continue to demonstrate that PH-762 may present a viable non-surgical alternative to existing modes of therapy for skin...
Immunic intends to use the net proceeds from the proposed offering to fund its clinical trials and operations and for other general corporate purposes.
The company said that the launch is in partnership with Tirana-based pharmaceutical company Pharma Cell, which will serve as the distributor in the country.
However, the company said that the study does not prove statistical significance and only involves a single administration of the antibody.
The company said that net proceeds from the offering will be used for the continued clinical development of product candidates, as working capital, and for other general corporate purposes.
Truist Securities noted that the numbers aligned with the company’s prior commentary and street estimates, although the shares could see headwinds today from Tesla reporting Q1 deliveries below estimates...